Jabez Biosciences Expands Phase 1 Trial of JBZ-001 with Second Clinical Site

Jabez Biosciences, Inc., a clinical-stage biopharmaceutical company dedicated to ushering in the future of cancer therapy with their seamless, scalable a...

August 18, 2025 | Monday | News
Invivyd Secures FDA Alignment on Single Phase 2/3 Trial Pathway for VYD2311 COVID-19 Prevention BLA

Alignment follows Type C meeting for VYD2311 as previously disclosed BLA pathway for VYD2311 to be supported by a single, Phase 2/3 randomized, doubl...

August 15, 2025 | Friday | News
Philips Commits $150M+ to U.S. Manufacturing and R&D, Expanding AI-Enabled Healthcare Capabilities

    Philips, a global leader in health technology,announced a plan for new investments of more than USD 150 million in U.S. manufacturi...

August 15, 2025 | Friday | News
Sarepta Advances SRP-1003 for DM1 Triggering $100 Million Milestone Payment to Arrowhead

Safety review leading to dose escalation and achievement of first predetermined enrollment target in Phase 1/2 study of SRP-1003 for DM1 triggers $100 ...

August 14, 2025 | Thursday | News
Rapid Micro Biosystems Secures $45 Million Loan Facility to Accelerate Global Growth of Growth Direct® System

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company prov...

August 14, 2025 | Thursday | News
Insmed Secures FDA Approval for BRINSUPRI™, the First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis

Approximately 500,000 U.S. Patients Are Diagnosed with Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung D...

August 14, 2025 | Thursday | News
Bionova Scientific Opens Texas pDNA Facility to Advance Cell and Gene Therapy Manufacturing

Bionova Scientific®, a full-service biologics contract development and manufacturing organization (CDMO) and subsidiary of global conglomerate Asahi ...

August 13, 2025 | Wednesday | News
Massive Bio and Prognos Health Forge Exclusive Partnership to Advance AI-Enabled Oncology Trial Matching

-Massive Bio, a leader in AI-enabled oncology trial matching and patient access, and Prognos Health, a provider of actionable lab data,  announced a...

August 13, 2025 | Wednesday | News
Amalgam Secures $20M Credit Investment from Catalio Capital to Accelerate Medical-Grade AI Expansion

 announced a $20 million credit investment from Catalio Capital Management, a leading investment firm dedicated to backing innovative healthcare com...

August 13, 2025 | Wednesday | News
Techcyte Integrates Modella AI’s PathChat™ into Fusion Research Platform to Advance AI-Powered Digital Pathology

-Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology,  announced that its platform, Techcyte Fusion&t...

August 13, 2025 | Wednesday | News
Dräger’s Atlan A350/A350XL Anesthesia Workstations Achieve U.S. DoD ATO Certification for Maximum Patient Data Security

Certification ensures highest level of patient data security a medical device can attain Effective 7/14/2025 and expiring on 7/14/2028 under eMASS ...

August 12, 2025 | Tuesday | News
Boehringer Ingelheim Secures FDA Accelerated Approval for HERNEXEOS® (Zongertinib) in HER2-Mutant Advanced NSCLC

HERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 75% (N=71), as demonstrated in the Beamion-LUNG 1 clinical trial ...

August 11, 2025 | Monday | News
LabConnect Partners with Kits4Life to Advance Sustainability in Clinical Trials

As part of our ongoing commitment to environmental stewardship and industry leadership in sustainable clinical research, LabConnect is proud to announce ...

August 08, 2025 | Friday | News
Intas Strengthens Global Leadership in Pegfilgrastim with UDENYCA® Acquisition

Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as one of the worl...

August 08, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close